Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT04288856 · TERMINATED
Trial details
- NCT number
- NCT04288856
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-28
- Primary completion
- 2022-05-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.